Table 3

Dose levels, doses, and first-cycle Cmaxs of Antagonist G in stage 2 of the Phase I clinical trial

Dose LevelDose (mg/m2)Patient No.No. of CyclesCmaxm)
1230016620.8
17430.2
18617.0
1335019320.9
201217.0
211226.0
1440022627.8
23345.5
24524.5